A randomized phase ll study of S-1 versus capecitabine as first-line chemotherapy in the elderly metastatic gastric cancer patients with/without poor performance status: clinical and pharmacogenetic results.

被引：0

作者：

Park, Sook Ryun ^{[1
]}

Kong, Sun-Young ^{[1
]}

Kim, Mi-Jung ^{[1
]}

Kim, Min Kyeong ^{[1
]}

Nam, Byung-Ho ^{[1
]}

Choi, Mihee ^{[1
]}

Park, Young-lee ^{[1
]}

机构：

[1] Natl Canc Ctr, Res Inst & Hosp, Goyang, South Korea

来源：

CANCER RESEARCH | 2013年 / 73卷 / 08期

关键词：

D O I：

10.1158/1538-7445.AM2013-LB-172

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LB172

引用

页数：1

共 50 条

[1] A randomized phase II study of S-1 versus capecitabine as first-line chemotherapy in elderly metastatic gastric cancer patients with or without poor performance status: clinical and pharmacogenetic results
Kim, Mi-Jung
Kong, Sun-Young
Nam, Byung-Ho
Kim, Sohee
Park, Young-Iee
Park, Sook Ryun
PHARMACOGENETICS AND GENOMICS, 2018, 28 (01): : 23 - 30
[2] A randomized multi-center phase II trial of capecitabine (X) versus S-1 (S) as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer
Kang, Y.
Lee, J.
Min, Y.
Lee, K.
Zang, D.
Ryoo, B.
Kim, J.
Park, S.
Kang, W.
Shin, D.
ANNALS OF ONCOLOGY, 2007, 18 : VII25 - VII25
[3] A randomized multi-center phase II trial of capecitabine (X) versus S-1 (S) as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer
Kang, Y.
Lee, J.
Min, Y.
Lee, K.
Zang, D.
Ryoo, B.
Kim, J.
Park, S.
Kang, W.
Shin, D.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[4] Docetaxel followed by capecitabine as first-line chemotherapy in metastatic breast cancer patients:: preliminary results.
Bayo, J
Salvador, J
Lomas, M
Ruiz, M
Baena, J
Vicente, D
Bernabé, R
Pineda, M
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 91S - 91S
[5] A phase II study of biweekly S-1 and paclitaxel (SPA) as first-line chemotherapy in patients with metastatic or advanced gastric cancer
Haiping Jiang
Jiong Qian
Peng Zhao
Xiaochen Zhang
Yi Zheng
Chenyu Mao
Yulong Zheng
Linghong Chen
Yao Wang
Haibo Mou
Weijia Fang
Lisong Teng
Nong Xu
Cancer Chemotherapy and Pharmacology, 2015, 76 : 197 - 203
[6] A phase II study of biweekly S-1 and paclitaxel (SPA) as first-line chemotherapy in patients with metastatic or advanced gastric cancer
Jiang, Haiping
Qian, Jiong
Zhao, Peng
Zhang, Xiaochen
Zheng, Yi
Mao, Chenyu
Zheng, Yulong
Chen, Linghong
Wang, Yao
Mou, Haibo
Fang, Weijia
Teng, Lisong
Xu, Nong
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (01) : 197 - 203
[7] A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer
J-L Lee
Y-K Kang
H J Kang
K-H Lee
D Y Zang
B-Y Ryoo
J G Kim
S R Park
W K Kang
D B Shin
M-H Ryu
H M Chang
T-W Kim
J H Baek
Y J Min
British Journal of Cancer, 2008, 99 : 584 - 590
[8] Clinical Study of S-1 Plus Oxaliplatin Versus S-1 Plus Cisplatin as First-Line Treatment for Elderly Patients with Advanced Gastric Cancer
Bo Deng-feng
Hu Xiu-fu
JOURNAL OF INTERNATIONAL TRANSLATIONAL MEDICINE, 2015, 3 (04): : 238 - 242
[9] First-line single-agent chemotherapy for patients with recurrent or metastatic gastric cancer with poor performance status
Hwang, Jun-Eul
Kim, Ha-Na
Kim, Dae-Eun
Shim, Hyun-Jeong
Bae, Woo-Kyun
Hwang, Eu-Chang
Cho, Sang-Hee
Chung, Ik-Joo
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2012, 4 (04) : 562 - 568
[10] A Phase II Study of Capecitabine plus Oxaliplatin as First-Line Chemotherapy in Elderly Patients with Advanced Gastric Cancer
Xiang, Xiao Jun
Zhang, Ling
Qiu, Feng
Yu, Feng
Zhan, Zheng Yu
Feng, Miao
Yan, Jun
Zhao, Jian Guo
Xiong, Jian Ping
CHEMOTHERAPY, 2012, 58 (01) : 1 - 7

← 1 2 3 4 5 →